Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]

Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
Published 2018
Publication Date:
2018-01-12
Publisher:
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
Print ISSN:
0090-9556
Electronic ISSN:
1521-009X
Topics:
Chemistry and Pharmacology
Medicine
Published by:
_version_ 1836398745514672129
autor Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
beschreibung Orally administered probiotics change gut microbiota composition and enzyme activities. Thus, coadministration of probiotics with drugs may lead to changes in the pharmacokinetic parameters of the drugs. In this study, we investigated the pharmacokinetics of acetaminophen in mice treated with probiotics. Oral administration of probiotics changed the gut microbiota composition in the mice. Of these probiotics, Lactobacillus reuteri K8 increased the numbers of clostridia, bifidobacteria, and enterococci, and Lactobacillus rhamnosus K9 decreased the number of bifidobacteria, determined by culturing in selective media. Next, we performed a pharmacokinetic study of acetaminophen in mice orally treated with K8 and K9 for 3 days. Treatment with K8 reduced the area under the curve (AUC) of orally administered acetaminophen to 68.4% compared with normal control mice, whereas K9 did not affect the AUC of acetaminophen. Oral administration to mice of K8, which degraded acetaminophen, increased the degradation of acetaminophen by gut microbiota, whereas K9 treatment did not affect it. Treatment with K8 increased the number of L. reuteri adhered in the upper small intestine, whereas the number of L. rhamnosus was not affected by treatment with K8 or K9. K8 increased the number of cyanobacteria, whereas K9 increased the number of deferribacteres. These results suggest that the intake of probiotics may make the absorption of orally administered drugs fluctuate through the disturbance of gut microbiota-mediated drug metabolism and that the subsequent impact on microbiota metabolism could result in altered systemic concentrations of the intact drug.
citation_standardnr 6137004
datenlieferant ipn_articles
feed_id 1915
feed_publisher The American Society for Pharmacology and Experimental Therapeutics (ASPET)
feed_publisher_url http://www.aspet.org/
insertion_date 2018-01-12
journaleissn 1521-009X
journalissn 0090-9556
publikationsjahr_anzeige 2018
publikationsjahr_facette 2018
publikationsjahr_intervall 7984:2015-2019
publikationsjahr_sort 2018
publisher The American Society for Pharmacology and Experimental Therapeutics (ASPET)
quelle Drug Metabolism and Disposition
relation http://dmd.aspetjournals.org/cgi/content/short/46/2/122?rss=1
search_space articles
shingle_author_1 Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
shingle_author_2 Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
shingle_author_3 Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
shingle_author_4 Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
shingle_catch_all_1 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
Orally administered probiotics change gut microbiota composition and enzyme activities. Thus, coadministration of probiotics with drugs may lead to changes in the pharmacokinetic parameters of the drugs. In this study, we investigated the pharmacokinetics of acetaminophen in mice treated with probiotics. Oral administration of probiotics changed the gut microbiota composition in the mice. Of these probiotics, Lactobacillus reuteri K8 increased the numbers of clostridia, bifidobacteria, and enterococci, and Lactobacillus rhamnosus K9 decreased the number of bifidobacteria, determined by culturing in selective media. Next, we performed a pharmacokinetic study of acetaminophen in mice orally treated with K8 and K9 for 3 days. Treatment with K8 reduced the area under the curve (AUC) of orally administered acetaminophen to 68.4% compared with normal control mice, whereas K9 did not affect the AUC of acetaminophen. Oral administration to mice of K8, which degraded acetaminophen, increased the degradation of acetaminophen by gut microbiota, whereas K9 treatment did not affect it. Treatment with K8 increased the number of L. reuteri adhered in the upper small intestine, whereas the number of L. rhamnosus was not affected by treatment with K8 or K9. K8 increased the number of cyanobacteria, whereas K9 increased the number of deferribacteres. These results suggest that the intake of probiotics may make the absorption of orally administered drugs fluctuate through the disturbance of gut microbiota-mediated drug metabolism and that the subsequent impact on microbiota metabolism could result in altered systemic concentrations of the intact drug.
Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
0090-9556
00909556
1521-009X
1521009X
shingle_catch_all_2 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
Orally administered probiotics change gut microbiota composition and enzyme activities. Thus, coadministration of probiotics with drugs may lead to changes in the pharmacokinetic parameters of the drugs. In this study, we investigated the pharmacokinetics of acetaminophen in mice treated with probiotics. Oral administration of probiotics changed the gut microbiota composition in the mice. Of these probiotics, Lactobacillus reuteri K8 increased the numbers of clostridia, bifidobacteria, and enterococci, and Lactobacillus rhamnosus K9 decreased the number of bifidobacteria, determined by culturing in selective media. Next, we performed a pharmacokinetic study of acetaminophen in mice orally treated with K8 and K9 for 3 days. Treatment with K8 reduced the area under the curve (AUC) of orally administered acetaminophen to 68.4% compared with normal control mice, whereas K9 did not affect the AUC of acetaminophen. Oral administration to mice of K8, which degraded acetaminophen, increased the degradation of acetaminophen by gut microbiota, whereas K9 treatment did not affect it. Treatment with K8 increased the number of L. reuteri adhered in the upper small intestine, whereas the number of L. rhamnosus was not affected by treatment with K8 or K9. K8 increased the number of cyanobacteria, whereas K9 increased the number of deferribacteres. These results suggest that the intake of probiotics may make the absorption of orally administered drugs fluctuate through the disturbance of gut microbiota-mediated drug metabolism and that the subsequent impact on microbiota metabolism could result in altered systemic concentrations of the intact drug.
Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
0090-9556
00909556
1521-009X
1521009X
shingle_catch_all_3 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
Orally administered probiotics change gut microbiota composition and enzyme activities. Thus, coadministration of probiotics with drugs may lead to changes in the pharmacokinetic parameters of the drugs. In this study, we investigated the pharmacokinetics of acetaminophen in mice treated with probiotics. Oral administration of probiotics changed the gut microbiota composition in the mice. Of these probiotics, Lactobacillus reuteri K8 increased the numbers of clostridia, bifidobacteria, and enterococci, and Lactobacillus rhamnosus K9 decreased the number of bifidobacteria, determined by culturing in selective media. Next, we performed a pharmacokinetic study of acetaminophen in mice orally treated with K8 and K9 for 3 days. Treatment with K8 reduced the area under the curve (AUC) of orally administered acetaminophen to 68.4% compared with normal control mice, whereas K9 did not affect the AUC of acetaminophen. Oral administration to mice of K8, which degraded acetaminophen, increased the degradation of acetaminophen by gut microbiota, whereas K9 treatment did not affect it. Treatment with K8 increased the number of L. reuteri adhered in the upper small intestine, whereas the number of L. rhamnosus was not affected by treatment with K8 or K9. K8 increased the number of cyanobacteria, whereas K9 increased the number of deferribacteres. These results suggest that the intake of probiotics may make the absorption of orally administered drugs fluctuate through the disturbance of gut microbiota-mediated drug metabolism and that the subsequent impact on microbiota metabolism could result in altered systemic concentrations of the intact drug.
Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
0090-9556
00909556
1521-009X
1521009X
shingle_catch_all_4 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
Orally administered probiotics change gut microbiota composition and enzyme activities. Thus, coadministration of probiotics with drugs may lead to changes in the pharmacokinetic parameters of the drugs. In this study, we investigated the pharmacokinetics of acetaminophen in mice treated with probiotics. Oral administration of probiotics changed the gut microbiota composition in the mice. Of these probiotics, Lactobacillus reuteri K8 increased the numbers of clostridia, bifidobacteria, and enterococci, and Lactobacillus rhamnosus K9 decreased the number of bifidobacteria, determined by culturing in selective media. Next, we performed a pharmacokinetic study of acetaminophen in mice orally treated with K8 and K9 for 3 days. Treatment with K8 reduced the area under the curve (AUC) of orally administered acetaminophen to 68.4% compared with normal control mice, whereas K9 did not affect the AUC of acetaminophen. Oral administration to mice of K8, which degraded acetaminophen, increased the degradation of acetaminophen by gut microbiota, whereas K9 treatment did not affect it. Treatment with K8 increased the number of L. reuteri adhered in the upper small intestine, whereas the number of L. rhamnosus was not affected by treatment with K8 or K9. K8 increased the number of cyanobacteria, whereas K9 increased the number of deferribacteres. These results suggest that the intake of probiotics may make the absorption of orally administered drugs fluctuate through the disturbance of gut microbiota-mediated drug metabolism and that the subsequent impact on microbiota metabolism could result in altered systemic concentrations of the intact drug.
Kim, J.-K., Choi, M. S., Jeong, J.-J., Lim, S.-M., Kim, I. S., Yoo, H. H., Kim, D.-H.
The American Society for Pharmacology and Experimental Therapeutics (ASPET)
0090-9556
00909556
1521-009X
1521009X
shingle_title_1 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
shingle_title_2 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
shingle_title_3 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
shingle_title_4 Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
timestamp 2025-06-30T23:31:58.176Z
titel Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
titel_suche Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice [Articles]
topic V
WW-YZ
uid ipn_articles_6137004